ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,502Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 783

$719K Total Retail Price of All Prescriptions

Rank: 127 out of 783

695 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 695 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 695 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,606 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 605 530 1 3
METFORMIN HCL 461 392 2 8
LISINOPRIL 433 370 3 4
FUROSEMIDE 407 359 4 7
LEVOTHYROXINE SODIUM 364 315 5 1
ATENOLOL 322 303 6 17
HYDROCHLOROTHIAZIDE 319 266 7 12
AMLODIPINE BESYLATE 314 293 8 5
GABAPENTIN 267 220 9 15
HYDROCODONE-ACETAMINOPHEN 264 236 S3 10 2
SYNTHROID 248 230 11 47
METOPROLOL TARTRATE 243 213 12 9
WARFARIN SODIUM 242 214 13 10
OMEPRAZOLE 205 183 14 6
LOVASTATIN 179 161 15 58
CITALOPRAM HBR 172 171 16 19
CLOPIDOGREL 156 140 17 29
ALENDRONATE SODIUM 153 151 18 25
ZOLPIDEM TARTRATE 152 124 19 23
METOPROLOL SUCCINATE 144 136 20 13
CARVEDILOL 142 106 21 21
NIFEDIPINE ER 141 104 22 135
ALLOPURINOL 138 109 23 31
ATORVASTATIN CALCIUM 133 113 24 11
PRAVASTATIN SODIUM 124 114 25 14
LOSARTAN POTASSIUM 119 116 26 18
FLUOXETINE HCL 114 93 27 45
GEMFIBROZIL 111 93 28 105
GLIPIZIDE ER 111 82 28 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 104 30 33
SERTRALINE HCL 110 67 30 22
TRAMADOL HCL 105 104 32 20
PROAIR HFA 95 38 33 56
COUMADIN 94 93 34 184
POTASSIUM CHLORIDE 94 88 34 16
LANTUS 89 64 36 38
ADVAIR DISKUS 85 72 37 50
AMITRIPTYLINE HCL 85 67 R 37 77
SPIRONOLACTONE 84 67 39 57
ZETIA 83 80 40 80
PLAVIX 82 77 41 51
DOXAZOSIN MESYLATE 80 78 42 87
CIPROFLOXACIN HCL 80 74 42 62
LOSARTAN-HYDROCHLOROTHIAZIDE 78 74 44 53
NEXIUM 77 48 45 28
LEVOXYL 77 69 45 150
MIRTAZAPINE 77 64 45 52
PANTOPRAZOLE SODIUM 74 65 48 30
KLOR-CON M20 73 66 49 48
ISOSORBIDE MONONITRATE ER 73 68 49 40
LANTUS SOLOSTAR 72 47 51 91
RAMIPRIL 69 57 52 113
TRAZODONE HCL 69 44 52 39
JANUVIA 67 61 54 73
AMLODIPINE BESYLATE-BENAZEPRIL 67 58 54 83
ESCITALOPRAM OXALATE 66 52 56 54
TAMSULOSIN HCL 66 66 56 26
TRIAMTERENE-HCTZ 65 50 58 42
BENAZEPRIL HCL 64 50 59 85
CRESTOR 62 59 60 27
ROPINIROLE HCL 62 53 60 74
PREDNISONE 55 54 62 36
OXYBUTYNIN CHLORIDE ER 55 36 62 117
DIGOXIN 54 42 64 61
NIFEDICAL XL 54 52 64 364
FLUTICASONE PROPIONATE 52 47 66 46
NITROFURANTOIN 52 51 66 225
GLIPIZIDE 52 49 66 71
DIOVAN 52 51 66 49
INSULIN SYRINGE 51 30 70 82
PROPRANOLOL HCL 50 50 71 129
DONEPEZIL HCL 50 50 71 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.